Achalasia: A brief review of treatment options and efficacy

Current Surgery

Volumn 59, Issue 6, 2002, Pages 549-553

  Garofalo, James H ^a   Pofahl, Walter E ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETROPIUM; DICYCLOVERINE; ISOSORBIDE DINITRATE; NIFEDIPINE; NITRIC ACID DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; TERBUTALINE; THEOPHYLLINE;

CARDIOESOPHAGOMYOTOMY; CLINICAL FEATURE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DENERVATION; ESOPHAGOGRAPHY; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS DILATATION; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MANOMETRY; HEADACHE; HEALTH CARE COST; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LONG TERM CARE; MORBIDITY; MYENTERIC PLEXUS; POSTGANGLIONIC NERVE; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0037069608     PISSN: 01497944     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7944(02)00658-X     Document Type: Note

References (25)

1. Podas T, Eaden J, Mayberry M, et al. Achalasia: a critical review of epidemiological studies. Am J Gastroenterol. 1998;93:2345.
2. Raymond L, Lach B, Shamji FM. Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology. 1999;35:453.
3. Holloway RH, Dodds WJ, Helm JF, et al. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology. 1986;90:924-929.
4. Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol. 1998;27(1): 21.
5. Howard PJ, Maher L, et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut. 1992;33:1011-1015.
6. Bartolotti M, Mari C, Lopilato C. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology. 2000;118:253-257.
7. Gideon RM, Castelli DO. Prospective randomized comparison of pneumatic dilatation technique in patients with idiopathic achalasia. Digestive Diseases and Sciences. 1999: 44:1853-1857.
8. Aagaard J, Kjaergaard H. Treatment of iatrogenic oesophageal perforation: diagnosed with delay. Ann Chir Gynaecol. 1991;80:346.
9. white RK, Morris DM. Diagnosis and management of esophageal perforations. American Surgeon. 1992;58:112.
10. Kadakia SC, Wong RKH. Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol. 1993;88:34-38.
11. Barkin JS, Guelrud M, Reiner DK, et al. Forceful balloon dilation: an outpatient procedure for achalasia. Gastrointestinal Endoscopy. 1990;36:123-126.
12. Wehrmann T, Jacobi V, Jung M, et al. Pneumatic dilation in achalasia with a low compliance balloon: results of a 5-year prospective evaluation. Gastrointestinal Endoscopy. 1995;42:31-36.
13. Anselmino M, Perdikis G, Hinder RA, et al. Heller myotomy is superior to dilatation for the treatment of early achalasia. Arch Surg. 1997;132:233-240.
14. Eckard VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103:1732-1738.
15. Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology. 1996;110:1410-1415.
16. Patti MG, Feo CV, Arcerito M, et al. Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia. Dig Dis Sci. 1999;44:2270-2276.
17. Bansal B, Koshy JM, Scheiman JM, et al. Interim analysis of a randomized trial of Witzel pneumatic dilation vs intrasphincteric injection of Botulinum toxin for achalasia, Gastroenterology. 1996;110:A57.
18. Vaezi M, Richter J, Wilcox M, et al. One-year follow-up: pneumatic dilatation more effective than botulinum toxin. Gastroenterology. 1997;112:A318.
19. Panaccione R, Gregor JC, Reynolds RPE, et al. Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis. Gastrointestinal Endoscopy. 1999;50:492-498.
20. Imperiale TF, O'Connor JB, Vaezi MF, et al. A costminimization analysis of alternative treatment strategies for achalasia. Am J Gastroenterol. 2000;95:2737-2745.
21. DeMeester TR, Stein HJ. Surgery for esophageal motor disorders. In: Castell DO, editor. The Esophagus. Boston: Little, Brown; 1992:401-439.
22. Csendes A, Braghetto I, Henriquez A, et al. Late results of a prospective randomized study comparing forceful dilatation and esophagomyotomy in patients with achalasia. Gut. 1989;30:299-304.
23. Okike N, Payne WS, Neufeld DM, et al. Esophagomyotomy versus forceful dilation for achalasia of the esophagus: results in 899 patients. Ann Thor Surg. 1979;28:119.
24. Seelig MH, DeVault KR, Seelig SK, et al. Treatment of achalasia: recent advances in surgery. J Clin Gastroenterol. 1999;28:202-207.
25. Hunter JG, Richardson WS. Surgical management of achalasia. Surg Clin N Am. 1997;77:993-1015.